248 related articles for article (PubMed ID: 27789083)
1. Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group.
Bendifallah S; Ouldamer L; Lavoue V; Canlorbe G; Raimond E; Coutant C; Graesslin O; Touboul C; Collinet P; Daraï E; Ballester M;
Gynecol Oncol; 2017 Jan; 144(1):107-112. PubMed ID: 27789083
[TBL] [Abstract][Full Text] [Related]
2. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.
Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M;
Ann Surg Oncol; 2017 Jun; 24(6):1660-1666. PubMed ID: 28058558
[TBL] [Abstract][Full Text] [Related]
3. Change in hazard rates of recurrence over time following diagnosis of endometrial cancer: An age stratified multicentre study from the FRANCOGYN group.
Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Bricou A; Huchon C; Daraï E; Ballester M;
Eur J Surg Oncol; 2018 Dec; 44(12):1914-1920. PubMed ID: 30217355
[TBL] [Abstract][Full Text] [Related]
4. Patterns of first recurrence and outcomes in surgically treated women with vulvar cancer: results from FRANCOGYN study group.
Pirot F; Chaltiel D; Ouldamer L; Touboul C; Raimond E; Carcopino X; Daraï E; Bendifallah S
J Gynecol Obstet Hum Reprod; 2020 Nov; 49(9):101775. PubMed ID: 32438137
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Recurrence, Long-term Survival and Toxicity Analysis of Endometrial Adenocarcinoma Patients Reclassified Under the Recent ESMO-ESGO-ESTRO Stratification: Seven-Year Results From a Single Institution.
Kumar UP; Yathiraj PH; Sharan KT; Kamath A; Singh A; Reddy SA; Alurkar P; Fernandes DJ; Mamidipudi VS
Int J Gynecol Cancer; 2018 Jun; 28(5):854-860. PubMed ID: 29683879
[TBL] [Abstract][Full Text] [Related]
6. Pattern of recurrence in patients with endometrial cancer: A retrospective study.
Vizza E; Cutillo G; Bruno V; Sperduti I; Mancini E; Baiocco E; Chiofalo B; Cicchillitti L; Certelli C; Zampa A; Piccione E; Corrado G
Eur J Surg Oncol; 2020 Sep; 46(9):1697-1702. PubMed ID: 32204935
[TBL] [Abstract][Full Text] [Related]
7. Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical staging.
Gultekin M; Guler OC; Yuce Sari S; Akkus Yildirim B; Onal C; Celik H; Yuce K; Ayhan A; Arik Z; Kose F; Altundag O; Zoto Mustafayev T; Atalar B; Bolukbasi Y; Yildiz F
J Obstet Gynaecol; 2021 Apr; 41(3):414-420. PubMed ID: 32347768
[TBL] [Abstract][Full Text] [Related]
8. The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study.
Buda A; Restaino S; Di Martino G; De Ponti E; Monterossi G; Dinoi G; Magni S; Quagliozzi L; Dell'Orto F; Ciccarone F; Lamanna M; Scambia G; Landoni F; Fanfani F
Eur J Surg Oncol; 2018 Oct; 44(10):1562-1567. PubMed ID: 30077521
[TBL] [Abstract][Full Text] [Related]
9. Severe Obesity Impacts Recurrence-Free Survival of Women with High-Risk Endometrial Cancer: Results of a French Multicenter Study.
Canlorbe G; Bendifallah S; Raimond E; Graesslin O; Hudry D; Coutant C; Touboul C; Bleu G; Collinet P; Darai E; Ballester M
Ann Surg Oncol; 2015 Aug; 22(8):2714-21. PubMed ID: 25503347
[TBL] [Abstract][Full Text] [Related]
10. A Proposal for a Classification for Recurrent Endometrial Cancer: Analysis of a French Multicenter Database From the FRANCOGYN Study Group.
Bricou A; Bendifallah S; Daix-Moreux M; Ouldamer L; Lavoue V; Benbara A; Huchon C; Canlorbe G; Raimond E; Coutant C; Graesslin O; Collinet P; Carcopino X; Touboul C; Daraï E; Carbillon L; Ballester M;
Int J Gynecol Cancer; 2018 Sep; 28(7):1278-1284. PubMed ID: 29994907
[TBL] [Abstract][Full Text] [Related]
11. Tumor Size, an Additional Prognostic Factor to Include in Low-Risk Endometrial Cancer: Results of a French Multicenter Study.
Canlorbe G; Bendifallah S; Laas E; Raimond E; Graesslin O; Hudry D; Coutant C; Touboul C; Bleu G; Collinet P; Cortez A; Daraï E; Ballester M
Ann Surg Oncol; 2016 Jan; 23(1):171-7. PubMed ID: 25952272
[TBL] [Abstract][Full Text] [Related]
12. Incidence, patterns and prognosis of first distant recurrence after surgically treated early stage endometrial cancer: Results from the multicentre FRANCOGYN study group.
Ouldamer L; Bendifallah S; Body G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Bricou A; Lavoué V; Lévêque J; Daraï E; Ballester M;
Eur J Surg Oncol; 2019 Apr; 45(4):672-678. PubMed ID: 30722948
[TBL] [Abstract][Full Text] [Related]
13. Recurrent patterns after postoperative radiotherapy for early stage endometrial cancer: A competing risk analysis model.
Ren K; Wang W; Sun S; Hou X; Hu K; Zhang F
Cancer Med; 2022 Jan; 11(1):257-267. PubMed ID: 34779587
[TBL] [Abstract][Full Text] [Related]
14. Honing the classification of high-risk endometrial cancer with inclusion of lymphovascular space invasion.
Bendifallah S; Perrin M; Ouldamer L; Lavoué V; Canlorbe G; Raimond E; Hudry D; Coutant C; Graesslin O; Touboul C; Collinet P; Daraï E; Ballester M;
Surg Oncol; 2017 Mar; 26(1):1-7. PubMed ID: 28317578
[TBL] [Abstract][Full Text] [Related]
15. Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group.
de Foucher T; Bendifallah S; Ouldamer L; Bricou A; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Monnier L; Graesslin O; Touboul C; Collinet P; Neveu ME; Huchon C; Daraï E; Ballester M;
Eur J Surg Oncol; 2019 Apr; 45(4):659-665. PubMed ID: 30685326
[TBL] [Abstract][Full Text] [Related]
16. Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group.
Reboux PA; Azaïs H; Canova CH; Bendifallah S; Ouldamer L; Raimond E; Hudry D; Coutant C; Graesslin O; Touboul C; Collinet P; Bricou A; Huchon C; Daraï E; Ballester M; Lévêque J; Lavoué V; Koskas M; Uzan C; Canlorbe G
J Gynecol Oncol; 2019 Jul; 30(4):e53. PubMed ID: 31074238
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer.
Vrede SW; van Weelden WJ; Visser NCM; Bulten J; van der Putten LJM; van de Vijver K; Santacana M; Colas E; Gil-Moreno A; Moiola CP; Mancebo G; Krakstad C; Trovik J; Haldorsen IS; Huvila J; Koskas M; Weinberger V; Bednarikova M; Hausnerova J; van der Wurff AA; Matias-Guiu X; Amant F; ; Snijders MPLM; Küsters-Vandevelde HVN; Reijnen C; Pijnenborg JMA
Gynecol Oncol; 2021 Jun; 161(3):787-794. PubMed ID: 33858677
[TBL] [Abstract][Full Text] [Related]
18. A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion.
Bendifallah S; Canlorbe G; Raimond E; Hudry D; Coutant C; Graesslin O; Touboul C; Huguet F; Cortez A; Daraï E; Ballester M
Br J Cancer; 2014 May; 110(11):2640-6. PubMed ID: 24809776
[TBL] [Abstract][Full Text] [Related]
19. Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?
Vrede SW; Donkers H; Reijnen C; Smits A; Visser NCM; Geomini PM; Ngo H; van Hamont D; Pijlman BM; Vos MC; Snijders MPLM; Kruitwagen R; Bekkers RLM; Galaal K; Pijnenborg JMA
J Obstet Gynaecol; 2024 Dec; 44(1):2294332. PubMed ID: 38186008
[TBL] [Abstract][Full Text] [Related]
20. [European guidelines (ESMO-ESGO-ESTRO consensus conference) for the management of endometrial cancer].
Ballester M; Bendifallah S; Daraï E
Bull Cancer; 2017 Dec; 104(12):1032-1038. PubMed ID: 29173977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
